NCT02065726 2025-05-01
Whey Protein Supplementation in Cancer Patients
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase NA Completed
Clinical Trials
5 trialsNCT03998345 2020-09-09
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase NA Unknown
NCT01369433 2020-09-01
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
AVEO Pharmaceuticals, Inc.
Phase NA Terminated
NCT02619045 2018-03-02
EVAL'COACH
Institut Claudius Regaud
Phase NA Completed
NCT00798889 2013-01-21
Rollover Protocol for Prior SU011248 Protocols
Pfizer
Phase NA Completed